356 related articles for article (PubMed ID: 38239049)
41. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
Staffas A; Burgos da Silva M; van den Brink MR
Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
[TBL] [Abstract][Full Text] [Related]
42. The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation.
Malard F; Jenq RR
Cancer J; 2023 Mar-Apr 01; 29(2):75-83. PubMed ID: 36957977
[TBL] [Abstract][Full Text] [Related]
43. Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation.
Gorshein E; Wei C; Ambrosy S; Budney S; Vivas J; Shenkerman A; Manago J; McGrath MK; Tyno A; Lin Y; Patel V; Gharibo M; Schaar D; Jenq RR; Khiabanian H; Strair R
Clin Transplant; 2017 May; 31(5):. PubMed ID: 28256022
[TBL] [Abstract][Full Text] [Related]
44. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
Golob JL; Pergam SA; Srinivasan S; Fiedler TL; Liu C; Garcia K; Mielcarek M; Ko D; Aker S; Marquis S; Loeffelholz T; Plantinga A; Wu MC; Celustka K; Morrison A; Woodfield M; Fredricks DN
Clin Infect Dis; 2017 Nov; 65(12):1984-1991. PubMed ID: 29020185
[TBL] [Abstract][Full Text] [Related]
45. Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice.
Bowerman KL; Varelias A; Lachner N; Kuns RD; Hill GR; Hugenholtz P
Gut Microbes; 2020 Jul; 11(4):754-770. PubMed ID: 31928131
[TBL] [Abstract][Full Text] [Related]
46. A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation.
Rayes A; Morrow AL; Payton LR; Lake KE; Lane A; Davies SM
Biol Blood Marrow Transplant; 2016 Mar; 22(3):418-22. PubMed ID: 26643031
[TBL] [Abstract][Full Text] [Related]
47. The gut microbiota and graft-versus-host disease.
Fredricks DN
J Clin Invest; 2019 May; 129(5):1808-1817. PubMed ID: 31042160
[TBL] [Abstract][Full Text] [Related]
48. Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure.
Daoud-Asfour H; Henig I; Ghersin I; Rakedzon S; Stern A; Pitashny M; Zuckerman T; Bar-Yoseph H
Transplant Cell Ther; 2022 Mar; 28(3):168.e1-168.e8. PubMed ID: 34954293
[TBL] [Abstract][Full Text] [Related]
49. Nutritional interventions in patients with graft-versus-host disease.
Seguy D; Hueso T
Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):455-462. PubMed ID: 37389472
[TBL] [Abstract][Full Text] [Related]
50. The Promise of Precision Nutrition for Modulation of the Gut Microbiota as a Novel Therapeutic Approach to Acute Graft-versus-host Disease.
Lakshmanan AP; Deola S; Terranegra A
Transplantation; 2023 Dec; 107(12):2497-2509. PubMed ID: 37189240
[TBL] [Abstract][Full Text] [Related]
51. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
52. [Fecal metabolomic profiles in experimental murine bone marrow transplantation].
Sekiguchi E; Toubai T; Suto M; Matsuki E; Miyata M; Ishizawa K
Rinsho Ketsueki; 2022; 63(1):37-44. PubMed ID: 35135950
[TBL] [Abstract][Full Text] [Related]
53. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis.
Riwes M; Reddy P
Semin Hematol; 2020 Jan; 57(1):1-6. PubMed ID: 32690138
[TBL] [Abstract][Full Text] [Related]
54. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial.
Andermann TM; Fouladi F; Tamburini FB; Sahaf B; Tkachenko E; Greene C; Buckley MT; Brooks EF; Hedlin H; Arai S; Mackall CL; Miklos D; Negrin RS; Fodor AA; Rezvani AR; Bhatt AS
Transplant Cell Ther; 2021 Nov; 27(11):932.e1-932.e11. PubMed ID: 34274493
[TBL] [Abstract][Full Text] [Related]
55. [Graft-versus-host disease: new insights into disease pathogenesis].
Hashimoto D
Rinsho Ketsueki; 2020; 61(8):959-964. PubMed ID: 32908061
[TBL] [Abstract][Full Text] [Related]
56. Gut microbiota trajectory in β-thalassemia major children who underwent allogeneic hematopoietic stem cell transplantation.
Luo H; Liu T; Qu Y; Kuang C; Xiao M; Sun J; Chen H; Wu J; Liu X; Jiang H
Transpl Infect Dis; 2023 Oct; 25(5):e14111. PubMed ID: 37615262
[TBL] [Abstract][Full Text] [Related]
57. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation.
Whangbo J; Ritz J; Bhatt A
Bone Marrow Transplant; 2017 Feb; 52(2):183-190. PubMed ID: 27526283
[TBL] [Abstract][Full Text] [Related]
58. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
Doki N; Suyama M; Sasajima S; Ota J; Igarashi A; Mimura I; Morita H; Fujioka Y; Sugiyama D; Nishikawa H; Shimazu Y; Suda W; Takeshita K; Atarashi K; Hattori M; Sato E; Watakabe-Inamoto K; Yoshioka K; Najima Y; Kobayashi T; Kakihana K; Takahashi N; Sakamaki H; Honda K; Ohashi K
Ann Hematol; 2017 Sep; 96(9):1517-1523. PubMed ID: 28733895
[TBL] [Abstract][Full Text] [Related]
59. Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection.
Ouyang J; Isnard S; Lin J; Fombuena B; Peng X; Nair Parvathy S; Chen Y; Silverman MS; Routy JP
Front Med (Lausanne); 2020; 7():421. PubMed ID: 32850913
[TBL] [Abstract][Full Text] [Related]
60. Clinical effects and applications of the gut microbiome in hematologic malignancies.
D'Angelo CR; Sudakaran S; Callander NS
Cancer; 2021 Mar; 127(5):679-687. PubMed ID: 33369893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
